Atea Pharmaceuticals
AVIR
AVIR
141 hedge funds and large institutions have $1.99B invested in Atea Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 57 funds opening new positions, 42 increasing their positions, 30 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
10% more call options, than puts
Call options by funds: $13M | Put options by funds: $11.8M
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
2.52% less ownership
Funds ownership: 71.18% → 68.67% (-2.5%)
Holders
141
Holding in Top 10
5
Calls
$13M
Puts
$11.8M
Top Buyers
| 1 | +$58M | |
| 2 | +$22.6M | |
| 3 | +$22.6M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$12.5M |
| 5 |
Goldman Sachs
New York
|
+$11.7M |
Top Sellers
| 1 | -$67.2M | |
| 2 | -$52M | |
| 3 | -$27.2M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$21.4M |
| 5 |
OFM
Omega Fund Management
Boston,
Massachusetts
|
-$20.4M |